Stamford, CT, United States of America

Ashmita Saigal

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ashmita Saigal: Innovator in Myointimal Proliferation Treatment

Introduction

Ashmita Saigal is a notable inventor based in Stamford, CT (US). She has made significant contributions to the field of medical treatments, particularly in addressing myointimal proliferation. Her innovative approach has the potential to impact patient care positively.

Latest Patents

Ashmita holds a patent for "Methods of treating myointimal proliferation." This invention provides a method of treating myointimal proliferation by administering a recombinant human soluble ectonucleotide pyrophosphatase phosphodiesterase (hsNPP1), active fragment, or fusion protein thereof. This advancement showcases her commitment to developing effective medical solutions.

Career Highlights

Throughout her career, Ashmita has worked with prominent organizations, including Inozyme Pharma, Inc. and Westfaelische Wilhelms-Universitaet Muenster. Her experience in these institutions has allowed her to refine her skills and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Yan Yan and Anumeha Shah. Their collaborative efforts have likely enhanced the quality and impact of her work in the field.

Conclusion

Ashmita Saigal's contributions to the treatment of myointimal proliferation highlight her innovative spirit and dedication to improving healthcare. Her patent and career achievements reflect her significant role in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…